Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid

European Journal of Endocrinology

Volumn 137, Issue 6, 1997, Pages 688-690

  Mansi, Luigi ^a,c   Rambaldi, Pier Francesco ^a   Panza, Nicola ^b   Esposito, Dario ^a   Esposito, Vincenzo ^a   Pastore, Vincenzo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CORTICOTROPIN; CORTODOXONE; DEXAMETHASONE; HYDROCORTISONE; HYDROXYPROGESTERONE; METYRAPONE; PENTETREOTIDE; PENTETREOTIDE IN 111; PRASTERONE SULFATE; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; BRONCHUS CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SCINTIGRAPHY;

ADULT; BRONCHIAL NEOPLASMS; CARCINOID TUMOR; CUSHING SYNDROME; HUMANS; MALE; SOMATOSTATIN;

EID: 0031452035     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370688     Document Type: Article

References (14)

1. Howlett TA, Rees LH & Besser GM. Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1985 14 911-945.
2. Colao A, Merola B, Tripodi FS, Di Sarno A, Esposito V, Marzullo P et al. Simultaneous and bilateral inferior petrosal synus sampling for diagnosis of Cushing's syndrome: comparison of multi-hormonal assay, baseline multiple sampling and ACTH-releasing hormone test. Hormone Research 1993 126 419-424.
3. Orth DN, Kovacs WS & De Bold CR. The adrenal cortex. In Textbook of Endocrinology, pp 489-620. Ed RH Williams. Philadelphia: WB Saunders, 1992.
4. Reubi JS, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW et al. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Research 1990 50 5969-5977.
5. Lamberts SWS, Krenning EP & Reubi JC. The role of somatostatin and its analogue in the diagnosis and treatment of tumors. Endocrine Reviews 1991 12 450-482.
6. Bertagna X, Favrod-Coune C, Escourelle H, Benzeboc P, Christoforov B, Girardi F et al. Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide. Journal of Clinical Endocrinology and Metabolism 1989 68 988-991.
7. Krenning EP, Bakker WH, Breeman WAP, Koper JW, Kooy PPM, Ausema L et al. Localisation of endocrine-related tumors with radioiodinated analogue of somatostatin. Lancet 1989 1 242-244.
8. Lamberts SWJ, Bakker WH, Reubi JC & Krenning EP. Somatostatin receptor in the localisation of endocrine-tumors. New England Journal of Medicine 1990 323 1246-1249.
9. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH & Besser GM. Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clinical Endocrinology 1986 24 699-713.
10. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Splinter TAW, Kho GS et al. Radioiodinated somatostatin analog scintigraphy in small cell lung cancer. Journal of Nuclear Medicine 1991 32 1845-1848.
11. Kirsch C-M, von Pauel J, Grau I & Tatsch K. Indium 111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma. European Journal of Nuclear Medicine 1994 21 1318-1325.
12. Phlipponneau M, Nocaudie M & Epelbaum J. Somatostatin analogs for the localisation and preoperative treatment of an ACTH-secreting bronchial carcinoid tumor. Journal of Clinical Endocrinology and Metabolism 1993 78 20-24.
13. de Herder WW, Krenning EP, Malchoff CD, Hofland LJ, Reubi JC, Kwekkeboom DJ et al. Somatostatin receptor scintigraphy: its value in tumor localisation in patients with Cushing's syndrome caused ectopic corticotropin or corticotropin-releasing hormone secretion. American Journal of Medicine 1994 96 305-312.
14. Malchoff CD, Orth DN, Abboud C, Carney JA, Pairolero PC & Carey RM. Ectopic ACTH syndrome caused by a bronchial carcinoid rumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor American Journal of Medicine 1988 84 760-764.